Oberweis Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Oberweis Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-41,200	Closed	-$976K	–	168
2021 Q1	$976K	Sell	41,200 -4,800	-10%	-$114K	0.2%	80
2020 Q4	$921K	Sell	46,000 -7,200	-14%	-$141K	0.24%	64
2020 Q3	$1.11M	Hold	53,200	–	–	0.37%	45
2020 Q2	$931K	Sell	53,200 -1,000	-2%	-$19.6K	0.37%	49
2020 Q1	$885K	Buy	54,200 +7,900	+17%	+$163K	0.49%	39
2019 Q4	$953K	Buy	+46,300	New	+$772K	0.32%	80

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Oberweis Asset Management's COLL Position: Q2 2021 in Review

Oberweis Asset Management sold out of Collegium Pharmaceutical (COLL) in Q2 2021, closing a stake of 41,200 shares — an estimated $976K sold.

Oberweis Asset Management first reported a position in COLL in Q4 2019 and held it in 6 quarters. The position peaked at $1.11M in Q3 2020. 158 funds tracked by Wall St. Rank hold COLL as of Q2 2021.

Oberweis Asset Management reported no remaining Collegium Pharmaceutical position as of Q2 2021 after selling out during the quarter.
Oberweis Asset Management sold 41,200 Collegium Pharmaceutical shares in Q2 2021, an estimated $976K.
Oberweis Asset Management first reported a position in Collegium Pharmaceutical in Q4 2019 and held it in 6 quarters.
Oberweis Asset Management's Collegium Pharmaceutical position peaked at $1.11M in Q3 2020.
158 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2021.

Based on Oberweis Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.